Published in Radiol Oncol on July 30, 2013
Machine Learning methods for Quantitative Radiomic Biomarkers. Sci Rep (2015) 1.19
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging. Clin Cancer Res (2014) 0.94
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One (2016) 0.89
Thyroid lesions incidentally detected by (18)F-FDG PET-CT - a two centre retrospective study. Radiol Oncol (2015) 0.85
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer. Front Oncol (2015) 0.85
Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis. Radiol Oncol (2015) 0.81
Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC. BMC Cancer (2014) 0.77
Is %ΔSUVmax a useful indicator of survival in patients with advanced nonsmall-cell lung cancer? ScientificWorldJournal (2013) 0.75
Role of PET and SPECT in the study of amyotrophic lateral sclerosis. Biomed Res Int (2014) 0.75
The role of PET-CT in radiotherapy planning of solid tumours. Radiol Oncol (2015) 0.75
2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer. Transl Oncol (2017) 0.75
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging (2010) 7.82
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med (2003) 7.64
Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med (1999) 3.20
Anatomy of SUV. Standardized uptake value. Nucl Med Biol (2000) 3.07
A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol (2010) 2.79
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol (2005) 2.30
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol (2004) 2.22
Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res (2007) 2.14
Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01
Lung cancer: diagnosis and management. Am Fam Physician (2007) 1.96
Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol (1999) 1.95
Prognostic value of FDG uptake in early stage non-small cell lung cancer. Eur J Cardiothorac Surg (2008) 1.77
The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer (2007) 1.76
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology (2012) 1.75
The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg (2005) 1.63
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol (2004) 1.33
Classification, staging and prognosis of lung cancer. Eur J Radiol (2003) 1.23
Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging (2011) 1.20
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. J Nucl Med (2011) 1.18
Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer. J Thorac Oncol (2008) 1.12
Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun (2002) 1.03
FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin (2009) 0.98
Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging. Radiol Oncol (2012) 0.85
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. Q J Nucl Med Mol Imaging (2004) 0.82
Endobronchial ultrasonography (EBUS)--its role in staging of non-small cell lung cancer and who should do it? J Thorac Cardiovasc Surg (2012) 0.79
Posttraumatic and iatrogenic foreign bodies in the heart: report of fourteen cases and review of the literature. J Thorac Cardiovasc Surg (2003) 2.61
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology (2013) 2.12
Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardiothorac Surg (2002) 1.79
Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging (2011) 1.48
Effectiveness of skeletal scintigraphy in transthyretin-related amyloidosis. Int J Cardiol (2013) 1.43
Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg (2009) 1.40
Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. Eur J Cardiothorac Surg (2010) 1.40
Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res (2005) 1.21
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.21
Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study. BMC Musculoskelet Disord (2005) 1.18
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging (2011) 1.11
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. Br J Haematol (2010) 1.09
Neuroendocrine tumors of the thymus. Thorac Surg Clin (2011) 1.09
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience. Pancreas (2014) 1.01
Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance. Eur J Cardiothorac Surg (2002) 1.00
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 0.98
Long-term follow-up of neonatally diagnosed primary megaureter: rate and predictors of spontaneous resolution. Scand J Urol Nephrol (2012) 0.97
The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatr Blood Cancer (2012) 0.95
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes. Thyroid (2013) 0.94
Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother (2004) 0.91
What is New on Thyroid Cancer Biomarkers. Biomark Insights (2008) 0.91
Is a complete urological evaluation necessary in all newborns with asymptomatic renal ectopia? Int J Urol (2007) 0.91
The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur J Cardiothorac Surg (2008) 0.91
Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg (2003) 0.90
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging (2014) 0.90
The treatment of large supratentorial arachnoid cysts in infants with cyst-peritoneal shunting and Hakim programmable valve. Childs Nerv Syst (2003) 0.89
Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study. Urol Int (2006) 0.89
Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging. Am J Rhinol (2006) 0.88
Stage I non-small cell lung carcinoma: really an early stage? Eur J Cardiothorac Surg (2002) 0.88
Synchronous bilateral typical carcinoid of the lung. Eur J Cardiothorac Surg (2003) 0.87
The role of surgery in recurrent thymic tumors. Thorac Surg Clin (2009) 0.87
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripher Nerv Syst (2012) 0.87
Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of graves' ophthalmopathy. Thyroid (2003) 0.86
Persistent cystic duct stump leak managed with hydrocoil embolization. Cardiovasc Intervent Radiol (2008) 0.86
Closure of an iatrogenic tracheo-esophageal fistula with bronchoscopic gluing in a mechanically ventilated adult patient. Ann Thorac Surg (2004) 0.86
Intrathoracic splenosis: a case report and an update of invasive and noninvasive diagnostic techniques. J Thorac Cardiovasc Surg (2007) 0.85
Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial. J Clin Endocrinol Metab (2014) 0.85
Radioiodine uptake in a renal cyst mimicking a metastasis in a patient affected by differentiated thyroid cancer: case report and review of the literature. Ann Nucl Med (2014) 0.84
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism. J Bone Miner Metab (2012) 0.83
Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up. AJR Am J Roentgenol (2015) 0.83
Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience. Eur J Cardiothorac Surg (2009) 0.83
Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy. Circ J (2011) 0.82
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Parkinsonism Relat Disord (2012) 0.82
Neuroendocrine tumors (carcinoid) of the thymic gland. Ann Thorac Surg (2003) 0.82
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease. Thyroid (2008) 0.82
Parathyroid carcinoma as a challenging diagnosis: report of three cases. Hormones (Athens) (2012) 0.82
Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis. J Crohns Colitis (2012) 0.81
124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma. Nucl Med Rev Cent East Eur (2015) 0.81
The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol (2014) 0.80
Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol (2013) 0.80
Primary choriocarcinoma of the lung. J Thorac Cardiovasc Surg (2003) 0.80
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer. Nucl Med Commun (2010) 0.80
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide. J Neurooncol (2007) 0.80
Transcranial Doppler ultrasonography in the assessment of cerebral circulation arrest: improving sensitivity by transcervical and transorbital carotid insonation and serial examinations. Neurocrit Care (2009) 0.80
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan. Ann Nucl Med (2013) 0.79
Gastrointestinal sequelae in survivors of congenital diaphragmatic hernia. Pediatr Int (2008) 0.79
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism. Clin Nucl Med (2012) 0.79
Absorbed fractions for alpha particles in ellipsoidal volumes. Phys Med Biol (2013) 0.78
Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience. Hell J Nucl Med (2015) 0.78
Vesicoureteral reflux: comparison between urosonography and radionuclide cystography. Pediatr Nephrol (2003) 0.78
Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Abdom Imaging (2015) 0.78
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma. J Nucl Med (2003) 0.78
Coronary-subclavian steal phenomenon late after coronary artery bypass grafting: an underappreciated cause of myocardial ischemia? J Cardiovasc Med (Hagerstown) (2009) 0.77
Comparison of MRI findings with traditional criteria in diagnosis of Pendred syndrome. Int J Audiol (2007) 0.77
Peptide receptor radionuclide therapy in patients with inoperable meningiomas: our experience and review of the literature. Cancer Biother Radiopharm (2014) 0.77
Acromegaly as manifestation of a bronchial carcinoid tumour. Asian Cardiovasc Thorac Ann (2003) 0.77
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg (2013) 0.76
Positron emission tomography. Ophthalmology (2012) 0.76
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? Thyroid (2014) 0.76
[Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results]. Chir Ital (2002) 0.76
Mid- and long-term effects on pulmonary perfusion, anatomy and diaphragmatic motility in survivors of congenital diaphragmatic hernia. Pediatr Surg Int (2005) 0.75
Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation. J Pediatr Surg (2006) 0.75
Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease. Radiol Case Rep (2015) 0.75
Intraoperative OctreoScan and management of bronchial carcinoid. Chest (2002) 0.75
Neuroendocrine tumors of the lung and octreotide scintigraphy. Ann Thorac Surg (2002) 0.75
Ectopic ACTH-producing tumors of the chest and octreotide scintigraphy. Eur J Cardiothorac Surg (2002) 0.75
Letter by Minutoli et al regarding article, "Reduced myocardial 123-iodine meta-iodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy". Circ Cardiovasc Imaging (2013) 0.75
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy. Nucl Med Commun (2013) 0.75
Possible Tx N2 M0 atypical bronchial carcinoid associated with Cushing syndrome. J Thorac Cardiovasc Surg (2003) 0.75
The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvement. Radiol Case Rep (2015) 0.75
Large-cell neuroendocrine carcinoma (LCNC) of the lung: a dilemma. Eur J Cardiothorac Surg (2003) 0.75
Is %ΔSUVmax a useful indicator of survival in patients with advanced nonsmall-cell lung cancer? ScientificWorldJournal (2013) 0.75
Re: Survival after extended thymectomy for thymoma. Eur J Cardiothorac Surg (2012) 0.75
A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients. Biomed Res Int (2013) 0.75
Recurrence of thymoma. Eur J Cardiothorac Surg (2011) 0.75
Large cell neuroendocrine carcinoma of the lung: what we have to do. J Thorac Cardiovasc Surg (2003) 0.75